breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria were as follows: a. without any therapy before the standard examination of 18F-FDG PET/CT; b. diagnosed with invasive carcinoma of breast cancer confirmed by puncture biopsy or surgical specimen; c. with available clinical records and pathological data; d. with IHC examination included the results of 4 molecular receptors performance (ER, PR, HER-2 and Ki-67).
Exclusion criteria
Exclusion criteria: Exclusion criteria were as follows: a. with a suboptimal quality of 18F-FDG PET/CT images due to motion artefacts or abnormal biodistribution of tracer; b. with a too small mass size to outline ROI for measurement (short-axis diameter <1 cm); c. concomitantly with other types of tumors; d. confirmed as other specific histological type of breast cancer e. total follow-up time was less than 8 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression-free survival time; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival time; | — |
Countries
China
Contacts
The First Affiliated Hospital of Soochow University